Showing 1 to 10 of 87 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Allogeneic Stem Cell Transplant for Children and Adolescents With Acute Lymoblastic Leukemia FORUM - Pharmacogenomic Study
FORUM NCT02670564  Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Pediatric |
Dr. David Mitchell Samira Mezziani 514-412-4400 poste 22930 |
|
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
ANBL1232 NCT02176967 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Pediatric |
Dr. Sharon Abish Katia Pamphile 514-412-4400 poste 22592 |
|
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-Like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
AALL1131 NCT01406756 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Pediatric |
Dr. Sharon Abish Margaret Hin-Chan 514-412-4400 poste 23543 |
|
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
ACNS0831 NCT01096368 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Pediatric |
Dr. Sharon Abish Katia Pamphile 514-412-4400 poste 22592 |
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
AGCT1531 NCT03067181 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Pediatric |
Dr. Sharon Abish Katia Pamphile 514-412-4400 poste 22592 |
|
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
COG-AALL1631 NCT03007147 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Pediatric |
Dr. Henrique Bittencourt Clemence Noury 514-345-4931 poste 6848 |
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
COG-AGCT1531 NCT03067181 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Pediatric |
Dr. Yvan Samson Martine Therrien 514-345-4931 poste 3396 |
|
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
COG-ANBL-1232 NCT02176967 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Pediatric |
Dr. Pierre Teira Martine Therrien 514-345-4931 poste 3396 |
|
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
COG-ANBL-1232 NCT02176967 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Marie-Christine Gagnon 418-525-4444 poste 40196 |
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
COG-AGCT-1531 NCT03067181 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Pediatric |
Dr. Bruno Michon Barbara Desbiens 418-525-4444 poste 40195 |
Groupe d'étude en oncologie du Québec